Childhood brain tumors develop early in highly specialized nerve cells, research reveals
A team of researchers at the Hopp Children's Cancer Center Heidelberg (KiTZ), the German Cancer Research Center (DKFZ) and Heidelberg...
Jul 8
Pediatric Brain Tumor Risk Increases With CT Radiation Exposure
Head and neck computed tomography (CT) imaging increases the risk for pediatric brain tumors, according to the findings of a study...
Jul 7
AI Predicts Pediatric Brain Tumor Relapse With Surprising Accuracy
Researchers have developed an AI system that predicts brain tumor recurrence in children using sequential MRI scans. [...] The approach...
Jul 4
FDA Grants Breakthrough Therapy Designation for BrainChild Bio’s B7-H3 CAR T-Cell Therapy for Incurable Pediatric Brain Tumors
BrainChild Bio, Inc., a clinical-stage biotechnology company developing CAR T-cell therapies to treat tumors in the central nervous...
Jun 28
Auditory Attention Decay Noted Post-Treatment in Pediatric Cerebellar Tumors
Quality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
Apr 17
FDA Grants Rare Pediatric Designation to Treatment With NEO100 in Brain Cancer
The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type...
Apr 10
Trial Shows Targeted Treatment for Childhood Brain Tumor is Safe
A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic...
Apr 7
Experimental treatment borrowed from blood cancer shows promise for pediatric brain tumors
In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts caution that...
Mar 24
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
Researchers and pediatric neurosurgeons at the University of Pittsburgh School of Medicine and UPMC Children's Hospital of Pittsburgh...
Mar 21
New therapeutic approach shows promise for pediatric high-grade gliomas
Paediatric high-grade gliomas (pHGG) in particular are a mostly fatal disease group with a median survival time of less than 18 months...
Mar 18